LYZZ Capital
Overview
LYZZ Capital is a global healthcare-dedicated venture capital and private equity firm that invests in innovative talents, assets, and technologies with a focus on unmet medical needs and market potential in China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai RNACure Biopharma Co., Ltd. | Mar 2021 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is LYZZ Capital based?
LYZZ Capital is headquartered in Shanghai, China.
When was LYZZ Capital founded?
LYZZ Capital was founded in 2017.
How many portfolio companies does LYZZ Capital have?
LYZZ Capital has 1 portfolio company in Caplight's dataset.
What are some companies in LYZZ Capital's portfolio?
Portfolio companies visible on Caplight include Shanghai RNACure Biopharma Co., Ltd..
What was LYZZ Capital's most recent investment shown here?
LYZZ Capital's most recent investment in this portfolio sample was in Shanghai RNACure Biopharma Co., Ltd. in 2021.
What sectors does LYZZ Capital focus on?
LYZZ Capital focuses on Healthcare & Life Sciences.
What company stages does LYZZ Capital focus on?
LYZZ Capital typically invests at the Early stage.
What is LYZZ Capital's AUM?
LYZZ Capital's assets under management are estimated at over $600.0M.